Cost-effectiveness of Extracorporeal Life Support Treatment

U

University Medical Center Groningen (UMCG)

Status

Unknown

Conditions

Critically Ill

Treatments

Behavioral: Health related Quality of life EQ-5D

Study type

Observational

Funder types

Other

Identifiers

NCT02837419
Dutch ECLS/2014/QoL

Details and patient eligibility

About

This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.

Full description

A direct comparison between usual care and ECLS treatment is difficult. Alternatively we compare predicted mortality for every patient based on validated scoring systems at the initiation of ECLS treatment with the actual outcome, so every patient is his own control. Primary outcome is HRQoL assessed with the EQ-5D questionnaire at 1 year. Healthcare costs and costs from a societal perspective are prospectively measured.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admitted to intensive care
  • Treated with extracorporeal life support

Exclusion criteria

none

Trial contacts and locations

0

Loading...

Central trial contact

Wim Dieperink, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems